glp 1 neurotransmitter Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports GLP-1 and the kidney: from

Then, we conducted a targeted metabolomics study using liquid chromatographymass spectrometry (LCMS) to assess the differences in the hepatic bile acid profile

Exposure to phentermine or GLP-1 medications in the first trimester yielded similar results to exposure in the 90 days prior to pregnancy, as shown in Figure 3

16 However, the burden of gastrointestinal side effects and challenges with long-term adherence limited its broader applicability and underscored the need for more effective and better-tolerated therapeutic alternatives

A promising therapeutic option is currently being developed in the context of the European research project called Rose (Restoring Odorant Detection and Recognition in Smell Deficit): the development of an artificial nose, an olfactory prosthesis that can restore odour perception in anosmic patients

134 OparilSAcelajadoMCBakrisGLBerlowitzDRCfkovRDominiczakAFet al